(NASDAQ:RGTI),(NASDAQ:RGTIW), BERKELEY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) — Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, today announced its financial results for the third quarter ended September 30, 2025. Third Quarter 2025 and Recent Financial Highlights Total revenues for the three months ended September 30, 2025 were […]

Solo Brands, Inc. to Present and Host 1×1 Meetings at the 17th Annual Southwest IDEAS Investor Conference on November 19, 2025 GlobeNewswire November 10, 2025 GRAPEVINE, Texas, Nov. 10, 2025 (GLOBE NEWSWIRE) — Solo Brands, Inc. (NYSE: SBDS) (“Solo Brands” or “the Company”) a leading portfolio of lifestyle brands (Solo Stove, Chubbies, Isle and Oru)

Quest Resource Holding Corporation Reports Third Quarter 2025 Financial Results GlobeNewswire November 10, 2025 Revenue and Adjusted EBITDA improvements of 6.4% and 9.5%, respectively from the prior quarter Reduced debt by $4.6 million in the quarter, bringing year-to-date debt reduction to $11.2 million Operating cash flow of $5.7 million improved 45% from the prior quarter

Perspective Therapeutics Provides Recent Business Highlights and Reports 3Q 2025 Results GlobeNewswire November 10, 2025 Updated interim results from the Company's [212Pb]VMT-α-NET Phase 1/2a study supporting the therapy's compelling overall clinical profile at the 5 mCi dose were presented at the ESMO Congress 2025, NANETS and Triple meetings Enrolled eight patients into Cohort 3 (6.0

(NYSE:COHR), SAXONBURG, Pa., Nov. 10, 2025 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), a global leader in photonics, today announced the launch of the EDGE CUT20 OEM Cutting Solution, pairing the new CUT20 laser cutting head with our EDGE FL20 fiber laser to deliver unmatched precision, control, and process intelligence for high-performance sheet-metal cutting. At

(NasdaqGM:OCS),(Iceland:OCS),(Iceland:OCS.IC), Oculis accelerates its portfolio development with Privosegtor moving into the PIONEER pivotal program in Acute Optic Neuritis (AON) and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) following positive FDA meeting OCS-01 DIAMOND Phase 3 trials in diabetic macular edema (DME) remain on track for topline results expected in Q2 2026 Licaminlimab PREDICT-1 registrational trial, the

SKYX Announces Corporate Update Call Including New Developments Company to Provide Corporate Updates Including New Developments, Third Quarter 2025 Overview and Financial Results; Conference Call to be Held Wednesday, November 12, 2025, at 4:30 P.M. Eastern Time GlobeNewswire November 10, 2025 MIAMI, Nov. 10, 2025 (GLOBE NEWSWIRE) — SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a “SKYX

Terns Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Updates GlobeNewswire November 10, 2025 Unprecedented Phase 1 CML efficacy data and potential best-in-disease profile of TERN-701 featured in ASH 2025 abstract Upcoming ASH oral presentation to feature expanded and updated dataset from CARDINAL trial Cash, cash equivalents and marketable securities of $295 million,

CapsoVision Submits Breakthrough Device Designation Application to FDA for Pancreatic Cancer Screening Capsule Non-invasive capsule endoscopy system aims to enable earlier detection of pancreatic ductal adenocarcinoma – among the most fatal cancers worldwide GlobeNewswire November 10, 2025 SARATOGA, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) — CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing

Beyond Air(R) Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update GlobeNewswire November 10, 2025 Increased revenue by 128% year over year (YoY) to $1.8 million Appointed Beyond Air Board member Bob Goodman as Interim Chief Commercial Officer Raised $12.0 million in debt financing; proforma cash, cash equivalents, restricted cash and marketable securities